Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Joan Wasserman"'
Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed
Autor:
Karin C. Berger, Brian M. Feldman, Joan Wasserman, Wolfgang Schramm, Victor Blanchette, Kathelijn Fischer
Publikováno v:
Haematologica, Vol 101, Iss 3 (2016)
Externí odkaz:
https://doaj.org/article/7d558e9e97474a4cb13262c925eb3f58
Autor:
Timothy B. Creedon, Meryl Sufian, Sarah Forrester, Benjamin Lê Cook, Jeroan J. Allison, Joan Wasserman
Publikováno v:
The Science of Health Disparities Research
Publikováno v:
Journal of obstetric, gynecologic, and neonatal nursing : JOGNN. 51(1)
Objective To examine the extent to which racial disparities exist in the perinatal outcomes of beneficiaries of the Military Health System (MHS). Data sources We searched the PubMed, CINAHL, and Embase databases. Study selection We selected articles
Autor:
Joan Wasserman, Marcia M. Gomez, Said A. Ibrahim, John Z. Ayanian, Rick Berzon, Richard C. Palmer
Publikováno v:
American Journal of Public Health. 109:S64-S69
Findings from health services research highlight continuing health care disparities in the United States, especially in the areas of access to health care and quality of care. Although attention to health care disparities has increased, considerable
Autor:
Joan Wasserman, Eliseo J. Pérez-Stable
Publikováno v:
Medical Care. 56:747-748
Publikováno v:
Journal of Neuroscience Nursing. 45:147-154
Because treatment for stroke has improved, individuals are living longer with the effects of a stroke. The resulting long-term impairment can affect both stroke survivors' and their caregivers' health-related quality of life (HRQOL). Few studies have
Autor:
Joan Wasserman, Brian M. Feldman, Karin C. Berger, Victor S. Blanchette, Krista Fischer, Wolfgang Schramm
Publikováno v:
Haematologica, 101(3), 266. Ferrata Storti Foundation
Policy makers and payers are increasingly mandating what physicians can prescribe and thus the need for proven evidence of the benefits and cost-effectiveness of new drugs has become imperative. A range of access hurdles are already in use. At their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bef0fbf892838acd2e79449deb40b8c
https://dspace.library.uu.nl/handle/1874/342489
https://dspace.library.uu.nl/handle/1874/342489
Publikováno v:
Haemophilia. 18:e154-e157
The very high cost of haemophilia care, including the increase in use of factor prophylaxis in both children and adults requires that funders of clotting factor concentrates require objective measures of health, such as joint status and quality of li
Publikováno v:
Topics in Stroke Rehabilitation. 18:676-684
This study aimed to capture direct costs of outpatient rehabilitative stroke care and medications for a 1-year period after discharge from inpatient rehabilitation.Outpatient rehabilitative services and medication costs for 1 year, during the time pe
Publikováno v:
Value in Health. 12(5):808-820
Introduction: One of the recent advances in assessing outcomes of medical care is the inclusion of the patient perspective. The term patient-reported outcome (PRO) is used to reflect the patient perceptions of disease and its consequences as well as